This inventor holds 1 USPTO granted patent. Top assignee: University of Strathclyde. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Solomon Habtemarium: Innovator in Psoriasis Treatment
Introduction
Solomon Habtemarium is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of dermatology, particularly in the treatment of psoriasis. His innovative approach utilizes natural compounds to address this challenging skin condition.
Latest Patents
Habtemarium holds a patent for the "Use of calendula glycosides for the treatment of psoriasis." This patent describes a method and compound that effectively treats diseases involving hyperproliferation of dermis cells. Specifically, compounds isolated from the calendula plant have been found to be beneficial in treating psoriasis. An extract of plant material obtained from calendula has been identified as an advantageous active compound in medicaments for psoriasis treatment.
Career Highlights
Solomon Habtemarium is affiliated with the University of Strathclyde, where he conducts research and develops innovative solutions for skin diseases. His work has garnered attention for its potential to improve the quality of life for individuals suffering from psoriasis.
Collaborations
Some of his notable coworkers include Chaman Lal Anand and Peter George Waterman. Their collaborative efforts contribute to advancing research in dermatological treatments.
Conclusion
Solomon Habtemarium's work exemplifies the intersection of nature and science in medical innovation. His contributions to psoriasis treatment highlight the importance of research in developing effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile